Codiak Biosciences Inc

+0.75 (+8.98%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)222.19M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.27 Million
Adjusted EPS-$0.83
See more estimates
10-Day MA$9.77
50-Day MA$12.52
200-Day MA$16.63
See more pivots

Codiak Biosciences Inc Stock, NASDAQ:CDAK

35 Cambridge Park Drive, Suite 500, Cambridge, Massachusetts 02140
United States of America
Phone: +1.617.949.4100
Number of Employees: 105


Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA.